These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R. Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119 [Abstract] [Full Text] [Related]
3. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience. Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF. Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025 [Abstract] [Full Text] [Related]
4. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W. Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129 [Abstract] [Full Text] [Related]
5. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R. Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156 [Abstract] [Full Text] [Related]
6. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials. DeVore RF, Jagasia M, Johnson DH. Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116 [Abstract] [Full Text] [Related]
7. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer. Natale RB. Semin Oncol; 1996 Oct; 23(5 Suppl 12):2-6. PubMed ID: 8941402 [Abstract] [Full Text] [Related]
8. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46). Johnson DH, Paul DM, Hande KR, DeVore R. Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120 [Abstract] [Full Text] [Related]
9. Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC). Langer CJ, McAleer CA, Bonjo CA, Litwin S, Millenson M, Kosierowski R, Blankstein K, Alexander R, Ozols RF. Eur J Cancer; 2000 Jan; 36(2):183-93. PubMed ID: 10741276 [Abstract] [Full Text] [Related]
10. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer. Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA. Clin Cancer Res; 1997 Jul; 3(7):1117-23. PubMed ID: 9815791 [Abstract] [Full Text] [Related]
11. Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer. Paccagnella A, Favaretto A, Oniga F, Ossana L. Semin Oncol; 1996 Dec; 23(6 Suppl 16):76-9. PubMed ID: 9007128 [Abstract] [Full Text] [Related]
12. A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study. Natale RB. Semin Oncol; 1995 Dec; 22(6 Suppl 15):34-7. PubMed ID: 8643968 [Abstract] [Full Text] [Related]
13. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial. Greco FA, Hainsworth JD. Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113 [Abstract] [Full Text] [Related]
14. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC). Glorieux P, Ortmanns P, Marien S, Degives R, Degraeve D, Potvin M, Grauwels D, Schallier D. Anticancer Res; 2001 Aug; 21(2B):1487-94. PubMed ID: 11396237 [Abstract] [Full Text] [Related]
15. Paclitaxel and carboplatin in inoperable non-small cell lung cancer. Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanasiadis A, Skarlos D. Semin Oncol; 1996 Dec; 23(6 Suppl 16):68-70. PubMed ID: 9007126 [Abstract] [Full Text] [Related]
16. Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer. Belani CP, Aisner J, Hiponia D, Engstrom C. Semin Oncol; 1995 Aug; 22(4 Suppl 9):7-12. PubMed ID: 7544028 [Abstract] [Full Text] [Related]
17. Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study. Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanassiadis A, Pavlidis N, Skarlos D. Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-30-S12-33. PubMed ID: 9331117 [Abstract] [Full Text] [Related]
18. Paclitaxel and carboplatin in nonoperable non-small cell lung cancer. Kosmidis P, Mylonakis N, Fountzilas G, Samantas E, Athanasiadis A, Skarlos D. Semin Oncol; 1996 Dec; 23(6 Suppl 15):16-8. PubMed ID: 8996591 [Abstract] [Full Text] [Related]
19. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer. Giaccone G, Huizing M, Postmus PE, ten Bokkel Huinink WW, Koolen M, van Zandwijk N, Vermorken JB, Beijnen JH, Dalesio O, Pinedo HM. Semin Oncol; 1995 Aug; 22(4 Suppl 9):78-82. PubMed ID: 7544030 [Abstract] [Full Text] [Related]
20. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ, Meyers FJ, Houston J, Lauder I. Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [Abstract] [Full Text] [Related] Page: [Next] [New Search]